Home
Epitope
Antibody
Variants
Tools
Statistics
Help
Details of Therapeutic
General Information
| Name | COVID-19 Conv. Plasma/Sera Convalescent plasma | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Alias | Convalescent plasma/sera collected from SARS-CoV-2 (variant unspecified) infected individuals. | ||||||||
| Therapeutic class | Plasma Convalescent plasma | ||||||||
| Mechanism | Immunostimulant | ||||||||
| Developer | ND | ||||||||
| Approval status | Research reagent | ||||||||
| Summary | Convalescent plasma/sera collected from SARS-CoV-2 (variant unspecified) infected individuals. | ||||||||
In vitro Activity Visualization
The x-axis indicates variants, and the y-axis indicates the -log value of in vitro activity fold
change
compared to WT or previous variants. Positive value indicates augmented neutralizing activity,
while negative indicates diminished.
Click to display detailed data for each scatter:
| Field | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | |||||||||
| Drug Class | |||||||||
| Viral Sublineage | |||||||||
| Viral Type | |||||||||
| Viral Protein | |||||||||
| Activity Fold Change | |||||||||
| -log(activity fold change) | |||||||||
| Viral aa Mutation | |||||||||
| Reference | |||||||||